[Temporary Announcement] Meifulun: 2025 Annual Equity Distribution Implementation Announcement
Announcement number: 2026-026
Securities code: 833784 Securities abbreviation: Meifulun Sponsoring broker: SDIC Securities
Beijing Meifulun Pharmaceutical Technology Co., Ltd.
2025 Annual Equity Distribution Implementation Announcement
The company and all members of the board of directors guarantee that there are no false records, misleading statements or major omissions in the announcement content, and bear individual and joint liability for the authenticity, accuracy and completeness of the content.
The 2025 annual equity distribution plan of Beijing Meifurun Pharmaceutical Technology Co., Ltd. has been reviewed and approved by the shareholders’ meeting on May 14, 2026. The equity distribution matters are now announced as follows:
The undistributed profits attributable to the parent company in the consolidated statement on the base date of this equity distribution were RMB 267,824,575.45, and the undistributed profits of the parent company were RMB 351,417,981.21. A total of RMB 2,477,016.66 in cash dividends was distributed during this equity distribution.
1. Equity distribution plan
- The company’s annual equity distribution plan for 2025 is:
Based on the company's existing total share capital of 82,567,222 shares, RMB 0.300000 in cash will be distributed to all shareholders for every 10 shares.
- Tax deduction instructions
(1) According to the relevant regulations on finance and taxation, individual shareholders and investment funds are subject to the differentiated personal income tax policy on dividends. If individual shareholders and securities investment funds hold shares for less than 1 month (including 1 month), they must pay back tax of 0.060000 yuan per 10 shares; if they hold shares for more than 1 month to 1 year (including 1 year), they must pay back taxes of 0.030000 yuan for every 10 shares; if they hold shares for more than 1 year, no back tax is required.
(2) Qualified Foreign Institutional Investors (QFII/RQFII) According to the provisions of Guo Shui Han [2009] No. 47, after the company withholds and pays income tax at a tax rate of 10%, it will actually distribute 0.270000 yuan per 10 shares.
(3) For institutional investors and legal person shareholders other than qualified foreign institutional investors, the company does not withhold and pay income tax, and the taxpayer shall pay it in the place where the income occurs.
Announcement number: 2026-026
2. Equity registration date and ex-rights and ex-dividend date
The equity registration date for this equity distribution is: May 26, 2026
The ex-rights and dividend date is: May 27, 2026
3. Equity allocation objects
The objects of this distribution are: all shareholders of the company registered with China Securities Depository and Clearing Co., Ltd. Beijing Branch (hereinafter referred to as "China Clearing Beijing Branch") as of the close of the National Equities Exchange and Quotations in the afternoon of May 26, 2026. Securities purchased by investors on R day (R day is the equity registration date) will enjoy relevant rights and interests; investors will not enjoy relevant rights and interests for securities sold by investors on R day.
4. Equity distribution method
- The cash dividends that the company entrusts China Securities Clearing Beijing Branch to distribute on its behalf will be directly transferred to its capital account through the shareholder custody securities company (or other custody institution) on May 27, 2026.
5. Contact information
Address: Room 1206, Building C, Building 1, No. 39 Chunhe Road, Daxing District, Beijing Contact person: Deng Wancai
Tel: 010-67085015 Fax: 010-67085015
6. Documents for reference
Resolution of the 19th meeting of the fourth board of directors of Beijing Meifulun Pharmaceutical Technology Co., Ltd.;
Beijing Meifurun Pharmaceutical Technology Co., Ltd. 2025 Annual Shareholders Meeting Resolution;
Beijing Meifulun Pharmaceutical Technology Co., Ltd. 2025 Annual Equity Distribution Plan Announcement
Board of Directors of Beijing Meifulun Pharmaceutical Technology Co., Ltd.
May 20, 2026